Edward H Cohen

Title: Edward H. Cohen: Innovator in Hematopoietic Stem Cell Research

Introduction

Edward H. Cohen, an accomplished inventor based in Somerville, MA, has made significant contributions to the field of hematopoietic stem cell research. With one patent to his name, his work is focused on advancing the understanding and potential applications of genetic and cellular therapies.

Latest Patents

Cohen's patented invention, "9804 gene and methods of use thereof," introduces a substantially pure preparation of DNA encoding a hematopoietic stem cell protein. This patent encompasses antibodies to the 9804 gene product, methods for purifying cells that express the 9804 gene, and ways to screen for homologs of the 9804 gene. This innovative approach holds promise for advancements in cellular therapy and regenerative medicine.

Career Highlights

Cohen's professional journey is marked by his association with Cytomed, Inc., a company dedicated to pioneering solutions in cellular and genetic medicine. His research emphasizes practical applications that can lead to breakthroughs in medical treatment, particularly for conditions related to hematopoietic stem cells.

Collaborations

Throughout his career, Cohen has collaborated with talented colleagues, including Bryan E. Landgraf. These partnerships enhance research outcomes and drive technological advancements in the medical field, furthering the impact of their innovative work.

Conclusion

Edward H. Cohen's contributions to hematopoietic stem cell research through his patent and collaborative efforts at Cytomed, Inc. exemplify the crucial role of inventors in advancing science and medicine. His work not only sheds light on the 9804 gene but also opens pathways for new therapeutic strategies.